Clinical trial
Efficacy of Topiramate for Weight Loss in Subjects With Metabolic Syndrome
NCT00243984 · Northeastern Ohio Universities College of Medicine, Other · Suspended
Key facts
| NCT number | NCT00243984 |
|---|---|
| Title | Efficacy of Topiramate for Weight Loss in Subjects With Metabolic Syndrome |
| Official title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Study to Assess the Efficacy of Topiramate for Weight Loss in Subjects With Metabolic Syndrome |
| Lead sponsor | Northeastern Ohio Universities College of Medicine, Other |
| Collaborators | Cleveland Clinic Akron General Forum Health Industry Aultman Health Foundation St. Elizabeth Health Center Mercy Medical Center |
| Status | Suspended |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Metabolic Syndrome X, Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | topiramate |
| Enrollment | 90 |
| Start date | Mar 1, 2005 |
| Completion | Nov 1, 2007 |
| First posted | Oct 25, 2005 |
| Last update posted | Dec 10, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: